webinar register page

RSV: The Next Frontier in Innovation

Respiratory Syncytial Virus (RSV) remains one of the last untapped vaccine markets in high-income countries, with the coming years proving to be pivotal in establishing the key players.

How important will first-to-market be? What impact will this have on treatment demand?

Airfinity is presenting a live industry roundtable, bringing together some of the leading experts in the RSV space to discuss the future of the market.

The panel:
- Fiona Thomas, Chief Medical Officer, KPMG
- Michael Greenberg, Vice President, Medical Head Vaccines, North America, Sanofi
- Victoria Jenkins, Director of Clinical Strategy, Bavarian Nordic

Hosted by Analytics Director Dr Matt Linley, you will get an exclusive look at Airfinity's independent analysis and forecasts which our panel will explore and provide their expert commentary on.

The session will include:
→ RSV prevalence and the existing treatments landscape
→ Vaccine pipeline overview and predictions
→ Factors involved in securing success with new candidates
→ Measuring future demand and market potential
→ Live Q&A with our panel

Don't miss your opportunity to hear from industry leaders on what promises to be one of the biggest emerging markets of 2023.

Register for free today.

Jan 31, 2023 04:00 PM in London